Inhibition of HCV replication in HCV replicon by shRNAs

被引：3
|
作者：
Hamazaki, Hiroyuki
Takahashi, Hitoshi
Shimotohno, Kunitada
Miyano-Kurosaki, Naoko
Takaku, Hiroshi
机构：
[1] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan
[2] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan
[3] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 606, Japan
来源：
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2006年 / 25卷 / 07期
关键词：
RNAi; long dsRNA; shRNA; HCVIRES/core; HCV replicon; anti-HCV;
D O I：
10.1080/15257770600726091
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
We show that the vector-derived long dsRNA specifically inhibits the replication of HCV RNA in HCV replicon. We designed a long dsRNA targeted to the full-length HCV IRES/core elements (1-to 377-nt). Our results revealed that the replication of HCV RNA was reduced to near background levels in a sequence-specific manner by the long dsRNAs in the HCV replicon. We also designed four shRNAs against several regions (120- to 139-nt, 260- to 279-nt, 330- to 349-nt, and 340- to 359-nt) of the HCV IRES/Core elements. The two HCV IRES/core-specific shRNAs, 330- to 349-nt and 340- to 359-nt, containing the AUG initiation codon sequence showed stronger HCV inhibitory effects than the other two shRNAs, 120- to 139-nt and 260- to 279-nt.
引用
收藏
页码：801 / 805
页数：5
相关论文
共 50 条
  • [41] HCV replicon inhibitors: Mode of action and resistance mapping
    Sarisky, RT
    THERAPY FOR VIRAL HEPATITIS AND PREVENTION OF HEPATOCELLULAR CARCINOMA, 2004, : 140 - 154
  • [42] HCV Replicon Systems: Workhorses of Drug Discovery and Resistance
    Khan, Shaheen
    Soni, Shalini
    Veerapu, Naga Suresh
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [43] INHIBITION OF HCV REPLICATION BY CCR5 BLOCKADE WITH CENICRIVIROC AND MARAVIROC
    Sherman, K. E.
    Kong, L.
    Blackard, J. T.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S684 - S684
  • [44] Fine tuning HCV replication
    Ashley York
    Nature Reviews Microbiology, 2017, 15 (2) : 66 - 66
  • [45] Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system
    Bost, AG
    Venable, D
    Liu, L
    Heinz, BA
    JOURNAL OF VIROLOGY, 2003, 77 (07) : 4401 - 4408
  • [46] LACK OF HCV REPLICATION DURING THE COURSE OF HCV-ASSOCIATED ARTHRITIS
    Riccio, A.
    Postiglione, L.
    Spano, A.
    Tarantino, G.
    EUROPEAN JOURNAL OF INFLAMMATION, 2008, 6 (03) : 141 - 142
  • [47] HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
    Wang, Yizhong
    Li, Jieliang
    Wang, Xu
    Zhou, Yu
    Zhang, Ting
    Ho, Wenzhe
    HEPATITIS MONTHLY, 2015, 15 (08)
  • [48] HCV-INFECTION-SPECIFIC MIRNAS CAPABLE OF REGULATING HCV REPLICATION
    Shirasaki, Takayoshi
    Honda, Masao
    Kawaguchi, Kazunori
    Shimakami, Tetsuro
    Horii, Rika
    Okada, Hikari
    Saito, Junichi
    Tokumaru, Norihiro
    Yi, MinKyung
    Lemon, Stanley M.
    Kaneko, Shuichi
    HEPATOLOGY, 2010, 52 (04) : 821A - 822A
  • [49] Anti-malarial drug chloroquine suppresses the replication of HCV replicon via PKR-independent mechanisms
    Mizui, Tomokazu
    Yamashina, Shunhei
    Takei, Yoshiyuki
    Ikejima, Kenichi
    Kitamura, Tsuneo
    Ueno, Takashi
    Kominami, Eiki
    Watanabe, Sumio
    HEPATOLOGY, 2007, 46 (04) : 458A - 458A
  • [50] HCV replicon inhibits gene induction by type III interferons
    Lowe, Rhiannon
    Morley, Peter
    Scott, Laurie
    Simecek, Nikol
    Thursz, Mark
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (08): : 732 - 733
12345